Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 96 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 96, Issue 6 (December 2014) In this issue In This Issue Editorial News & Views Perspectives Discovery & Development State of the Art Research Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe In This Issue Top In This Issue Clin Pharmacol Ther 2014 96: 627; 10.1038/clpt.2014.194 Full Text Editorial Top Mitochondrial Pharmacology: Its Future Is Now H H Szeto, L P James and A J Atkinson Clin Pharmacol Ther 2014 96: 629-633; 10.1038/clpt.2014.177 Abstract | Full Text News & Views Top HIGHLIGHTS Clin Pharmacol Ther 2014 96: 634-635; 10.1038/clpt.2014.193 Full Text ASCPT NEWS Clin Pharmacol Ther 2014 96: 636-640; 10.1038/clpt.2014.189 Full Text MACROSCOPY Fast-Tracking the Development of Effective Therapeutics in Mitochondrial Medicine S P Hersh Clin Pharmacol Ther 2014 96: 641-643; 10.1038/clpt.2014.163 Full Text Perspectives Top POINT-COUNTERPOINT The Mitochondria in Heart Failure: A Target for Coenzyme Q10 Therapy? S A Mortensen and A L Mortensen Clin Pharmacol Ther 2014 96: 645-647; 10.1038/clpt.2014.175 Full Text Should Administration of Coenzyme Q10 Be Recommended to Patients with Congestive Heart Failure? M M Reidenberg Clin Pharmacol Ther 2014 96: 647-649; 10.1038/clpt.2014.166 Full Text Meaningful Use of Pharmacogenetics M J Ratain and J A Johnson Clin Pharmacol Ther 2014 96: 650-652; 10.1038/clpt.2014.188 Full Text Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing A C J W Janssens and P A Deverka Clin Pharmacol Ther 2014 96: 652-654; 10.1038/clpt.2014.186 Full Text COMMENTARY Evidence Required to Demonstrate Clinical Utility of Pharmacogenetic Testing: The Debate Continues N K Gillis and F Innocenti Clin Pharmacol Ther 2014 96: 655-657; 10.1038/clpt.2014.185 Abstract | Full Text LETTERS TO THE EDITOR Erlotinib and Gastric Acid–Reducing Agents: A Combination to Avoid or to Support? T H Oude Munnink, J H Schouwink, H B B Colen and K L L Movig Clin Pharmacol Ther 2014 96: 658; advance online publication, August 13, 2014; 10.1038/clpt.2014.164 Full Text Response to “Erlotinib and Gastric Acid–Reducing Agents: A Combination to Avoid or to Support?” L Zhang, S C Lee, H Zhao, F Wu and L Zhang Clin Pharmacol Ther 2014 96: 659; advance online publication, September 23, 2014; 10.1038/clpt.2014.192 Full Text Clarification of Enrolled Subjects in Tolvaptan HF Trials J Blais, J Chiodo, III, K Friend and S Shoaf Clin Pharmacol Ther 2014 96: 660; advance online publication, September 18, 2014; 10.1038/clpt.2014.190 Full Text Response to “Clarification of Enrolled Subjects in Tolvaptan HF Trials” A M Feldman, E Hamad, E Tsai, W Zhu, D G Tilley, R Alvarez and J Y Cheung Clin Pharmacol Ther 2014 96: 661; advance online publication, September 18, 2014; 10.1038/clpt.2014.191 Full Text Discovery & Development Top TRANSLATION Targeting mitochondrial oxidants may facilitate recovery of renal function during infant sepsis C R Sims, L A MacMillan-Crow and P R Mayeux Clin Pharmacol Ther 2014 96: 662-664; advance online publication, August 22, 2014; 10.1038/clpt.2014.170 Abstract | Full Text In Vitro Assays of Mitochondrial Function/Dysfunction T A Than, S Win and N Kaplowitz Clin Pharmacol Ther 2014 96: 665-668; advance online publication, September 10, 2014; 10.1038/clpt.2014.178 Full Text DEVELOPMENT In Vivo Metabolic Spectroscopy Identifies Deficits in Mitochondrial Quality and Capacity in Aging Skeletal Muscle D J Marcinek and K E Conley Clin Pharmacol Ther 2014 96: 669-671; advance online publication, September 10, 2014; 10.1038/clpt.2014.179 Full Text State of the Art Top Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity H H Szeto and A V Birk Clin Pharmacol Ther 2014 96: 672-683; advance online publication, September 4, 2014; 10.1038/clpt.2014.174 Abstract | Full Text Research Top ARTICLES Cytochrome P450 Epoxygenase Dependence of Opioid Analgesia: Fluconazole Does Not Interfere With Remifentanil-Mediated Analgesia in Human Subjects B G Oertel, J Vermehren, T T Huynh, A Doehring, N Ferreiros, M Zimmermann, G Geisslinger and J Lötsch Clin Pharmacol Ther 2014 96: 684-693; advance online publication, August 22, 2014; 10.1038/clpt.2014.169 Abstract | Full Text Dual Glutathione-S-Transferase-θ1 and -μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia A Davies, A Giannoudis, J E Zhang, G Austin, L Wang, T L Holyoake, M C Müller, L Foroni, P D Kottaridis, M Pirmohamed and R E Clark Clin Pharmacol Ther 2014 96: 694-703; advance online publication, September 4, 2014; 10.1038/clpt.2014.176 Abstract | Full Text GSK2374697, a Novel Albumin-Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin-4: First Study in Humans—PK/PD and Safety R L O’Connor-Semmes, J Lin, R J Hodge, S Andrews, J Chism, A Choudhury and D J Nunez Clin Pharmacol Ther 2014 96: 704-712; advance online publication, September 19, 2014; 10.1038/clpt.2014.187 Abstract | Full Text Clopidogrel Bioactivation and Risk of Bleeding in Patients Cotreated With Angiotensin-Converting Enzyme Inhibitors After Myocardial Infarction: A Proof-of-Concept Study K E Kristensen, H-J Zhu, X Wang, G H Gislason, C Torp-Pedersen, H B Rasmussen, J S Markowitz and P R Hansen Clin Pharmacol Ther 2014 96: 713-722; advance online publication, September 15, 2014; 10.1038/clpt.2014.183 Abstract | Full Text Risk Management Plans as a Tool for Proactive Pharmacovigilance: A Cohort Study of Newly Approved Drugs in Europe N S Vermeer, R G Duijnhoven, S M J M Straus, A K Mantel-Teeuwisse, P R Arlett, A C G Egberts, H G M Leufkens and M L De Bruin Clin Pharmacol Ther 2014 96: 723-731; advance online publication, September 15, 2014; 10.1038/clpt.2014.184 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.